INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 275 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,555,449 | -4.2% | 276,393 | +3.2% | 0.05% | 0.0% |
| Q2 2023 | $11,018,933 | +93.6% | 267,905 | +170.2% | 0.05% | +85.7% |
| Q1 2023 | $5,692,431 | -33.6% | 99,154 | -35.2% | 0.03% | -41.7% |
| Q4 2022 | $8,578,093 | -7.9% | 152,989 | -30.4% | 0.05% | -4.0% |
| Q3 2022 | $9,311,000 | +29.4% | 219,796 | +65.1% | 0.05% | +35.1% |
| Q2 2022 | $7,193,000 | +22.9% | 133,133 | +46.2% | 0.04% | +12.1% |
| Q1 2022 | $5,853,000 | +2204.3% | 91,088 | +2377.2% | 0.03% | +1550.0% |
| Q1 2021 | $254,000 | -95.4% | 3,677 | -95.7% | 0.00% | -95.7% |
| Q4 2020 | $5,561,000 | -5.7% | 85,658 | -31.4% | 0.05% | -4.1% |
| Q3 2020 | $5,896,000 | +555.1% | 124,859 | +552.2% | 0.05% | +390.0% |
| Q2 2020 | $900,000 | -41.7% | 19,145 | -44.6% | 0.01% | -77.3% |
| Q1 2020 | $1,544,000 | -31.2% | 34,574 | -10.2% | 0.04% | 0.0% |
| Q4 2019 | $2,243,000 | – | 38,487 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tributary Capital Management, LLC | 414,578 | $28,291,000 | 2.14% |
| Champlain Investment Partners, LLC | 6,510,030 | $444,244,000 | 2.11% |
| COOKE & BIELER LP | 2,750,361 | $187,685,000 | 1.74% |
| Sapience Investments, LLC | 161,660 | $11,032,000 | 1.37% |
| Laurus Investment Counsel Inc. | 35,933 | $3,043,000 | 0.94% |
| Hood River Capital Management LLC | 432,824 | $29,536,000 | 0.88% |
| Mitsubishi UFJ Asset Management (UK) Ltd. | 23,400 | $1,597,000 | 0.69% |
| GW&K Investment Management, LLC | 726,682 | $49,589,000 | 0.43% |
| Olstein Capital Management, L.P. | 46,000 | $3,139,000 | 0.40% |
| Quantinno Capital Management LP | 5,088 | $347,000 | 0.39% |